SITREP #006 · WEEKLY SITUATION REPORT · 17–23 AUG 2026
The Contraction Lasted Exactly One Week
Overnight ATS notional rebounded 59 percent to $25.7B. Memory took 33.9 percent of the tape, the highest share in the nine-week series. And the year's largest biotech re-rating, a 1,700x one-night jump in Moderna's overnight notional, still could not crack the tape's top nine single names.
00BLUF
Last week's edition asked whether a third week of contraction would make the thinning tape a regime. The answer arrived in five sessions: no. BlueOcean overnight notional ran $25.67B against $16.15B the week prior, a 59 percent rebound that retraces most of the two-week decline. The heaviest single night, Tuesday at $8.22B across three venues, was the busiest since the July 31 peak week.
What came back was not a broader tape. It was memory. On the basket pinned in #005, the semiconductor complex retook 56.7 percent of BlueOcean notional and memory alone printed 33.9 percent, the highest share in the series. SanDisk carried $3.93B for the week, the single largest symbol on the tape, ahead of Micron at $2.80B and the geared semiconductor ETFs. The "first week under half" lasted exactly one week.
The week also delivered a clean natural experiment. Moderna's positive Phase 3 melanoma readout on Wednesday produced one of the year's largest single-session re-ratings, and the overnight tape's response was a $237M print from a name whose median night all summer was $365K. That is a 1,700x jump on the prior night, and it still only ranks tenth among single names for the week. Event flow spikes; the memory complex compounds.
//The Stack
Five layers of market plumbing, and where each one stands this week. Click any layer for the detail.
01The Tape Came Back
Three-venue overnight activity totaled $30.49B for the week. Tuesday was the heaviest session at $8.22B and the back half faded, with Thursday and Friday under $5B each. One venue-level note: Moon ATS reported no activity for the Friday session, on its own public data as well as in our pipeline, so Friday's total reflects two venues. We have an open question in with the operator side; the other two venues printed normally all five nights.
Memory is now a third of the overnight tape
The three memory names, SanDisk, Micron and SK hynix, carried $8.09B between them, 31.5 percent of BlueOcean's weekly notional on their own. Across 1,310 symbols, the top five took 44.4 percent of the tape and the top ten took 56.2. The rebound made the tape heavier, not broader.
The names underneath
| Symbol | Name | Week notional | Median TD | Theme |
|---|---|---|---|---|
| SNDK | SanDisk | $3.93B | -58.9 bps | Memory, #1 on the tape |
| MU | Micron | $2.80B | +58.0 bps | Memory |
| SKHY | SK hynix | $1.36B | +27.9 bps | Korea memory |
| SPCX | SpaceX exposure | $491M | -144.8 bps | Private-market wrapper |
| INTC | Intel | $411M | -49.4 bps | Compute |
| NVDA | Nvidia | $374M | +6.3 bps | Reports Aug 26 |
| NBIS | Nebius | $360M | -117.1 bps | AI infrastructure |
| AMD | AMD | $296M | -103.5 bps | Compute |
| MRVL | Marvell | $287M | +34.6 bps | Reports Aug 27 |
| MRNA | Moderna | $284M | +8.8 bps | Phase 3 event flow |
Note the split inside memory itself: SanDisk's median timing differential ran -58.9 basis points against Micron's +58.0 in the same week, on the two heaviest symbols on the tape. The overnight session was consistently paying up for one memory name relative to its subsequent open and consistently underpricing the other. Nvidia, which reports Wednesday, ran a near-flat +6.3 basis points on $374M, the calmest large print in the table.
02A Gap That Ran Both Ways
Last week's edition flagged sessions where the overnight bid did not carry into the opening print. This week produced the sharper version: the two measures disagreed by double digits in both directions, in consecutive sessions.
| Session | Traded above prior close | Opened above prior close | Gap |
|---|---|---|---|
| MON | 72.2% | 51.9% | 20.3 pp |
| TUE | 29.5% | 30.6% | -1.1 pp |
| WED | 40.4% | 68.3% | -27.9 pp |
| THU | 71.6% | 37.5% | 34.1 pp |
| FRI | 77.6% | 83.0% | -5.4 pp |
Wednesday night, the session after the Moderna readout, only 40.4 percent of symbols traded above their prior close overnight, yet 68.3 percent opened above it. The overnight tape was 28 points more cautious than the morning turned out to be. Thursday night inverted: 71.6 percent bid overnight, 37.5 percent opened higher, a 34-point gap in the opposite direction and the widest in either direction across the two editions we have tracked it.
Two consecutive sessions, two double-digit disagreements, opposite signs. Whatever the overnight session was pricing this week, the opening auction repriced it, twice.
The honest read stays the same as last week, with more evidence: overnight positioning and opening price discovery are different mechanisms run by different participants, and in event weeks the handoff between them is loose. Friday, with the event flow spent, the two measures converged to within six points.
03The Event the Tape Absorbed
On Wednesday, August 19, Merck and Moderna announced that the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met both survival endpoints in resected melanoma, the first late-stage success for an mRNA cancer vaccine. Moderna closed the session at $174.38 against $62.96 the day before, then gave roughly a quarter of it back on Thursday.
The overnight tape's response is the cleanest single-name event print in the series so far:
| Session | MRNA overnight notional |
|---|---|
| Sun night | $200K |
| Mon night | $500K |
| Tue night | $100K |
| Wed night | $237.0M |
| Thu night | $46.0M |
A name whose median overnight print all summer was $365K, and which had not cleared $5M on any single night, printed $237.0M on the session after the readout, then $46.0M the night after that. The spike is enormous in relative terms and modest in absolute ones: $237M ranks below every core memory and semiconductor name for the week. The overnight market repriced a $24B biotech overnight, and the tape's structure barely moved. That asymmetry, huge relative response inside a narrow absolute footprint, is what an institutionally concentrated session looks like from the inside.
04One Venue Filing
One Form ATS-N amendment landed in the window. On August 17, IntelligentCross filed a Material Amendment introducing functionality that lets a subscriber send orders to the ATS and have them forwarded to the IntelligentCross SOR without entering the ATS matching engine. Routing is opt-in only, and a subscriber can invoke it two ways: a per-order FIX tag designating a specific SOR strategy, or a session-level configuration keyed to order attributes such as type, time-in-force, display instructions or size.
The mechanics are narrow but the role change is not. An ATS offering itself as a front door to its operator's router, for orders that never touch its own book, sits somewhere between a venue and an access layer. The filing also discloses what order information the ATS passes to the SOR for opted-in subscribers, which is the detail a routing desk will want to read in full. Source: Form ATS-N/MA, accession 0001708826-26-000015, filed August 17, 2026.
For the two venue filings covered in depth last edition, PureStream's operator- classified Liquidity Maker pool and OneChronos's pre-market extension, the full analysis remains at Two Venues, Opposite Moves.
05What We Published
Five reports since SITREP #005, all on execution economics and measurement. Together they form a single argument: the public files measure less than they appear to, and what they do measure is worth reading closely.
06Forward Calendar
- Nvidia reports Wednesday, August 26, after the close. Consensus revenue sits near $92B. Nvidia ran the calmest large print on our tape this week, +6.3 basis points median on $374M. Whether that composure survives the print is the single best test of the overnight session's read on the AI cycle. Marvell follows Thursday.
- Core PCE prints Wednesday morning, Jackson Hole runs Thursday to Saturday. The Fed chair speaks Friday morning. An inflation print and a policy address bracketing the Nvidia report makes Wednesday to Friday the densest macro stretch since July.
- Does memory hold a third of the tape? 33.9 percent is the series high. One week is a print; two would start to look like the summer concentration reasserting itself at a higher level.
- Does Moon print Sunday night? Friday was the first session in the life of our pipeline where Moon itself reported zero activity on an otherwise healthy feed. Whether Sunday's session resumes normally is the first thing we will know Monday morning.
07Get SITREP
SITREP goes out Sunday evenings. The daily intelligence briefs run seven times a weekday around the global session handoffs. Both are free to subscribe to, and you can pick which ones you want below.
Get SITREP and the intelligence briefs
SITREP is published Sunday evenings: one read on what moved in market structure, the overnight tape, and the filings behind both. Tell us what you actually want and we will only send that.
Sources
- Sapinover three-venue overnight pipeline (BlueOcean, Bruce Markets, Moon ATS). BlueOcean figures computed from BlueOcean_Master_Historical.parquet, GitHub Release
pipeline-data, covering 2025-09-02 through 2026-08-21, breadth and reference-gap measures on complete rows only. Moon ATS reported no activity for the August 21 session; Friday totals reflect two venues. - Semis basket as pinned in SITREP #005: memory (MU, SNDK, SKHY, DRAM) plus SOXL, SOXS, AMD, NVDA, INTC, MRVL, KORU, EWY. Every overlapping week matches the published series.
- IntelligentCross, LLC (CIK 0001708826). Form ATS-N/MA filed August 17, 2026 (accession 0001708826-26-000015), amendment statement per Instruction A.7(g).
- Merck and Moderna, joint announcement of Phase 3 INTerpath-001 results, August 19, 2026. Moderna price levels from consolidated regular-session closes.
- Forward calendar: Nvidia fiscal Q2 report scheduled August 26; core PCE August 26; Kansas City Fed Jackson Hole symposium August 27 to 29, per public schedules as of August 23.
SITREP is a weekly situation report on market structure, published Sundays. Overnight notional figures reflect Sapinover's three-venue pipeline and are not comparable to full-market consolidated volume. This analysis is for information only and is not investment advice, a recommendation, or a solicitation. For methodology see the support page.